USP8与TP53驱动基因与侵袭性促肾上腺皮质激素腺瘤的拷贝数变异相关
提示促肾上腺皮质激素腺瘤可分基因组稳定型(USP8突变)与基因组破坏型(USP8野生型,部分TP53突变)。
要点
- USP8与TP53突变互斥,可能为独立驱动基因。
- USP8野生型肿瘤拷贝数变异广泛,与侵袭性和大腺瘤相关。
- 广泛拷贝数变异或有助于识别需密切监测的高危肿瘤。
核心结论
- 促肾上腺皮质激素腺瘤可分为USP8突变基因组稳定型与USP8野生型基因组破坏型,后者包含TP53突变且染色体高度不稳定。
- 广泛拷贝数变异可能帮助识别需密切监测和更积极治疗的高危促肾上腺皮质激素腺瘤。
研究设计与样本
- 患者队列富集了具有侵袭性行为风险的肿瘤,研究在三级医疗中心开展。
主要发现
- USP8和TP53存在反复体细胞突变,等位基因分数高于其他体细胞突变。
- USP8与TP53突变互斥,TP53突变仅见于USP8野生型肿瘤。
- USP8野生型肿瘤相比USP8突变肿瘤具有广泛体细胞拷贝数变异。
- 侵袭性、大腺瘤与非整倍体相关,且独立于分子驱动状态。
临床怎么用
- 对促肾上腺皮质激素腺瘤可依据USP8突变状态和拷贝数变异进行分子分型。
- 广泛拷贝数变异者可能需更密切监测和更积极治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Pituitary corticotroph adenomas are rare tumors that can be associated with excess adrenocorticotropin (ACTH) and adrenal cortisol production, resulting in the clinically debilitating endocrine condition Cushing disease. A subset of corticotroph tumors behave aggressively, and genomic drivers behind the development of these tumors are largely unknown. OBJECTIVE: To investigate genomic drivers of corticotroph tumors at risk for aggressive behavior. DESIGN: Whole-exome sequencing of patient-matched corticotroph tumor and normal deoxyribonucleic acid (DNA) from a patient cohort enriched for tumors at risk for aggressive behavior. SETTING: Tertiary care center. PATIENTS: Twenty-seven corticotroph tumors from 22 patients were analyzed. Twelve tumors were macroadenomas, of which 6 were silent ACTH tumors, 2 were Crooke's cell tumors, and 1 was a corticotroph carcinoma. INTERVENTION: Whole-exome sequencing. MAIN OUTCOME MEASURE: Somatic mutation genomic biomarkers. RESULTS: We found recurrent somatic mutations in USP8 and TP53 genes, both with higher allelic fractions than other somatic mutations. These mutations were mutually exclusive, with TP53 mutations occurring only in USP8 wildtype (WT) tumors, indicating they may be independent driver genes. USP8-WT tumors were characterized by extensive somatic copy number variation compared with USP8-mutated tumors. Independent of molecular driver status, we found an association between invasiveness, macroadenomas, and aneuploidy. CONCLUSIONS: Our data suggest that corticotroph tumors may be categorized into a USP8-mutated, genome-stable subtype versus a USP8-WT, genome-disrupted subtype, the latter of which has a TP53-mutated subtype with high level of chromosome instability. These findings could help identify high risk corticotroph tumors, namely those with widespread CNV, that may need closer monitoring and more aggressive treatment.
引用
- Uzilov AV, Taik P, Cheesman KC, et al. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors. J Clin Endocrinol Metab. 2021. PMID: 33221858. doi:10.1210/clinem/dgaa853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。